- News & Events
NewsSee all recent news
May 20th, 2020
Presentation of “SPI2” Phase III Results at the EAN Virtual Congress 2020Read more
March 10th, 2020
MedDay Reports Top-Line Data from Phase III Trial “SPI2” for Treatment of Progressive Forms of Multiple SclerosisRead more
December 12th, 2019
MedDay Reports Last Patient Study Visit in Second Phase 3 Clinical Trial with MD1003®, an Important Milestone Towards Completion of the SPI2 Study in Progressive Multiple SclerosisRead more
July 22nd, 2019
MedDay Pharmaceuticals to webcast key opinion leader meeting on new treatment strategies for progressive forms of multiple sclerosis tomorrowRead more
EventsSee all events
October 03 2019
MedDay attends the 32nd congress of "Association des Neurologues Libéraux de Langue française" (ANLLF) in Strasbourg, France
September 11 2019
MedDay attends the 35th congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Stockholm, Sweden. Excited to meet you on our booth C60!
June 29 2019
MedDay attends the 5th congress of the European Academy of Neurology (EAN) in Oslo, Norway. Meet us Booth C34!
May 28 2019
MedDay attends the 2019 Consortium of Multiple Sclerosis Centers (CMSC) Meeting in Seattle, Washington. Meet us at our booth!
April 16 2019